FDA approves Daurismo for newly diagnosed AML ineligible for intensive chemotherapy Nov. 22, 2018 No Comments
FDA grants approval for Adcetris as first-line treatment for peripheral T-cell lymphoma Nov. 19, 2018 No Comments
European Commission approves Cabometyx for HCC previously treated with sorafenib Nov. 15, 2018 No Comments
France becomes first country to market baclofen preparation to reduce alcohol consumption Oct. 29, 2018 No Comments
RSS